These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 138999)

  • 1. Concomitant immunopathology with squamous cell carcinomas of the head and neck regions.
    Berlinger NT; Good RA
    Trans Sect Otolaryngol Am Acad Ophthalmol Otolaryngol; 1976; 82(5):588-94. PubMed ID: 138999
    [No Abstract]   [Full Text] [Related]  

  • 2. A correlative analysis of in vitro parameters of cellular immunity in patients with squamous cell carcinoma of the head and neck.
    Deegan MJ; Coulthard SW; Quaiman SJ; Schork MA
    Cancer Res; 1977 Dec; 37(12):4475-81. PubMed ID: 144562
    [No Abstract]   [Full Text] [Related]  

  • 3. Preservation of in vitro biological functions in regional lymph node lymphocytes in squamous head and neck cancer.
    Saxon A; Portaro J
    Cancer Res; 1977 Apr; 37(4):1159-64. PubMed ID: 139203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular immune response in squamous cell carcinomas of head and neck: evaluation by histological indices.
    Ariz M; Ahmad KN; Khan AA; Hasan SA
    Indian J Pathol Microbiol; 1986 Oct; 29(4):392-9. PubMed ID: 3817970
    [No Abstract]   [Full Text] [Related]  

  • 5. Identification of subsets of lymphocytes infiltrating head and neck tumor tissue: a preliminary report.
    Rabin BS; Johnson J; Claassen D
    Laryngoscope; 1984 May; 94(5 Pt 1):688-90. PubMed ID: 6232437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expansion of tumor-infiltrating lymphocytes from human solid tumors in interleukin-2.
    Whiteside TL; Heo DS; Chen K; Adler A; Johnson JT; Herberman RB
    Prog Clin Biol Res; 1987; 244():213-22. PubMed ID: 3309998
    [No Abstract]   [Full Text] [Related]  

  • 7. Cellular immunity in patients with epidermoid cancer of the head and neck.
    Papenhausen PR; Kukwa A; Croft CB; Borowiecki B; Silver C; Emeson EE
    Laryngoscope; 1979 Apr; 89(4):538-49. PubMed ID: 311881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transference of cell mediated immunity in patients with head and neck cancer.
    Vetto RM; Burger DR
    Laryngoscope; 1978 Jan; 88(1 Pt 2 Suppl 8):79-82. PubMed ID: 304143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Total lymphocyte and T lymphocyte subpopulation levels in head and neck squamous cell carcinomas.
    Soysal V; Yigitbasi OG; Alper M; Patiroglu T; Güney E
    J Exp Clin Cancer Res; 1998 Jun; 17(2):207-12. PubMed ID: 9700582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of immunocompetent cells in patients with head and neck squamous cell carcinoma.
    Dawson DE; Everts EC; Vetto RM; Burger DR
    Ann Otol Rhinol Laryngol; 1985; 94(4 Pt 1):342-5. PubMed ID: 3875306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor antigen phenotype, biologic staging, and prognosis in head and neck squamous carcinoma.
    Wolf GT; Carey TE
    J Natl Cancer Inst Monogr; 1992; (13):67-74. PubMed ID: 1389697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of combined immunotherapy with levamisole and Bacillus Calmette-Guérin on immunocompetence of patients with squamous cell carcinoma of the cervix, head and neck, and lung undergoing radiation therapy.
    Olkowski ZL; McLaren JR; Skeen MJ
    Cancer Treat Rep; 1978 Nov; 62(11):1651-61. PubMed ID: 310339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enrichment in tumor-reactive CD8+ T-lymphocytes by positive selection from the blood and lymph nodes of patients with head and neck cancer.
    Letessier EM; Heo DS; Okarma T; Johnson JT; Herberman RB; Whiteside TL
    Cancer Res; 1991 Aug; 51(15):3891-9. PubMed ID: 1677310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship of circulating IgA to cellular immunity in head and neck cancer patients.
    Schantz SP; Liu FJ; Taylor D; Beddingfield N; Weber RS
    Laryngoscope; 1988 Jun; 98(6 Pt 1):671-8. PubMed ID: 3259661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presence of activated T lymphocytes in peripheral blood of head and neck squamous cell carcinoma patients predicts impaired prognosis.
    Aarstad HJ; Heimdal JH; Klementsen B; Olofsson J; Ulvestad E
    Acta Otolaryngol; 2006 Dec; 126(12):1326-33. PubMed ID: 17101596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphoid subpopulation changes in regional lymph nodes in squamous head and neck cancer.
    Saxon A; Portis J
    Cancer Res; 1977 Apr; 37(4):1154-8. PubMed ID: 300279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of radiotherapy on cellular immunity of patients with head and neck cancers].
    Misaki T; Arai K; Konishi J; Abe M; Torizuka K; Makimoto K; Nesumi N
    Nihon Gan Chiryo Gakkai Shi; 1986 Dec; 21(10):2371-6. PubMed ID: 3494798
    [No Abstract]   [Full Text] [Related]  

  • 18. [Autologous lymphocytotoxicity against squamous cell carcinoma in head and neck. I. In vitro culture of squamous cell carcinoma in head and neck (author's transl)].
    Ikawa T
    Nihon Jibiinkoka Gakkai Kaiho; 1981 Dec; 84(12):1570-8. PubMed ID: 7341742
    [No Abstract]   [Full Text] [Related]  

  • 19. An immunological outcome predictive score for head and neck carcinoma patients.
    Kaffenberger W; Hölzer-Müller L; Auberger T; Clasen BP; Hohlmeier G; van Beuningen D
    Strahlenther Onkol; 1995 Aug; 171(8):444-53. PubMed ID: 7652667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant vaccinia virus expressing interleukin-2 invokes anti-tumor cellular immunity in an orthotopic murine model of head and neck squamous cell carcinoma.
    Dasgupta S; Bhattacharya-Chatterjee M; O'Malley BW; Chatterjee SK
    Mol Ther; 2006 Jan; 13(1):183-93. PubMed ID: 16125469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.